Auto Accident Cases
Plane Crash Results
Construction Accident Cases
Defective Product Cases
Medical Malpractice Cases
Amusement Park Cases
Gulf Oil Spill Accident
Airplane Accident
Amputations
Amusement Park Accidents
Asbestos Exposure
ATV Accidents
Auto Accidents
Benzene
Bicycle Accidents
Boating Accidents
Brain Injury Cases
Broken Bones and Fractures
Burn and Scar Injury Cases
Bus Accidents
Catastrophic Injury
Construction & Scaffold Accidents
Dangerous Drugs
Defective Products
Dog Bites
Farming Accidents
Lead Paint Poisoning
Medical Malpractice
Motorcycle Accidents
Pedestrian Accidents
Railroad Accidents
Serious Injuries
Slip & Fall Injury Accident
Spinal Cord Injury Cases
Swimming Accidents
Truck Accidents
Workers Comp Third Party Claim
Wrongful Death
Scholarship and Community
Accreditations
Consumer Health Information Updates
MedWatch Safety Alerts
Recall News
Video Library
Frequently Asked Questions
Thank You Letters
Personal Injury Information Center
Scholarship and Community
Accreditations
Consumer Health Information Updates
MedWatch Safety Alerts
Recall News
Video Library
Frequently Asked Questions
Thank You Letters
Thank You Letters
Thank You Letters
Thank You Letters
Tell us about your case.
Over $40 Million
Brain Injury
+ Read More
$12.5 Million Settlement
Burn Victim
+ Read More
Over $65 Million
Settlement from International Corporation
Read more
$3 Million Scaffold Accident
Spinal Injury
+ Read More
Multi Million Dollar Plane Crash
Wrongful Death
+ Read More
MedWatch Safety Alerts
Title
Description
Pub Date
Tygacil (tigecycline): Label Change - Increased Mortality Risk
Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
1-Sep-2010
Huber Needles: Recall - Risk of Coring
Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient’s lungs.
26-Aug-2010
Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices.
26-Aug-2010
TimeOut Capsules: Undeclared Drug Ingredient
Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
25-Aug-2010
MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient
UPDATED 08/25/2010. Product marketed as dietary supplement contains undeclared Aminotadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
25-Aug-2010
Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events
Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.
25-Aug-2010
Mr. Magic Male Enhancer: Undeclared Drug Ingredient
Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil and sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
24-Aug-2010
INOMAX DS Drug-Delivery System: Class I Recall - Risk of Interruption of Drug Flow
Potential for failure of a pressure switch, which may have an impact on the administration of INOMAX for inhalation to patients.
23-Aug-2010
Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk
FDA evaluating clinical trial data that suggest patients taking drug may be at an increased risk for cardiovascular events compared to those taking carbidopa/levodopa
19-Aug-2010
Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug
Companies failed to provide evidence of clinical benefit of midodrine hydrochloride because required post-approval studies that verify the clinical benefit of the drug have not been done.
16-Aug-2010
Manhattan Office
:
405 Lexington Avenue
26th Floor, Chrysler Building
New York, New York 10174
(800) 621-2020
Maps & Directions
Garden City Office
1225 Franklin Avenue
Suite 325
Garden City
,
NY
11530
(800) 621-2020
Map & Directions
Melville Office
445 Broadhollow Road
Suite 205
Long Island, NY 11747
(800) 621-2020
Map & Directions
Buffalo Office:
2500 Main Place Tower
350 Main Street
Buffalo, New York 14202
(716) 854-2020
(800) 621-2020
Map & Directions
Rochester Office:
16 West Main Street
Powers Building, Suite 600
Rochester, New York 14614
(585) 454-2020
(800) 621-2020
Map & Directions
Grider Street Office:
451 Grider Street
Buffalo, New York 14215
(716) 854-2020
(800) 621-2020
Map & Directions
Site Map
|
Disclaimer
|
Design by Scorpion Design
|
Administration